The Melbourne pre-diabetes study: Prediction of type 1 diabetes mellitus using antibody and metabolic testing

Medical Journal of Australia

Volumn 169, Issue 2, 1998, Pages 81-84

  Colman, Peter G ^a,b   McNair, Peter ^a,c   Margetts, Heather ^a,b   Schmidli, Robert S ^a,c   Werther, George A ^e,f   Alford, Frank P ^g   Ward, Glenn M ^g   Tait, Brian D ^a,d   Honeyman, Margo C ^a,c   Harrison, Leonard C ^a,c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b Dept of Diabetes and Endocrinology ^*

^c Div of Autoimmunity and Transplant

^d Department of Pathology

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f Centre for Hormone Research

^g ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PHOSPHATASE; TYROSINE;

ADULT; ANTIBODY DETECTION; ARTICLE; CELL FUNCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MAJOR CLINICAL STUDY; METABOLISM; PANCREAS ISLET BETA CELL; PARENT; PREDICTION; PROGENY; RELATIVE; SIBLING;

EID: 0032551674     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb140188.x     Document Type: Article

References (20)

1. Harrison LC, Campbell IL, Colman PG, et al. type 1 diabetes: immunopathology and immunotherapy. Adv Endocrinol Metab 1990; 1: 36-94.
2. Feutren G, Papoz L, Assan R, et al. Cyclosporin increases the rate and length of remissions in insulin dependent diabetes of recent onset: results of multicenter double blind trial. Lancet 1986; 2: 119-123.
3. Harrison LC, Colman PG, Dean BM, et al. Increase in remission rate in newly diagnosed type 1 diabetic subjects treated with azathioprine. Diabetes 1985; 34: 1306-1308.
4. Srikanta S, Ganda OP, Rabizadeh A, et al. First-degree relatives of patients with type 1 diabetes mellitus. Islet cell antibodies and abnormal insulin secretion. N Engl J Med 1985; 313: 461-464.
5. Tarn AC, Thomas JM, Dean BM, et al. Predicting insulin-dependent diabetes. Lancet 1988; 1: 845-850.
6. Riley WJ, Maclaren NK, Krischer J, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990; 323: 1167-1172.
7. Bingley PJ for the ICARUS group. Interactions of age, islet cell antibodies, insulin autoantibodies, and firstphase insulin response in predicting risk of progression to IDDM in ICA + relatives. The ICARUS data set. Diabetes 1996; 45: 1720-1728.
8. Ziegler AG, Ziegler R, Vardi P, et al. Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type 1 diabetes. Diabetes 1989; 38: 1320-1325.
9. Baekkeskov S, Aanstoot H, Christgau S, et al. Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesising enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156.
10. Petersen JS, Hejnaes KR, Moody A, et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459-467.
11. Rabin DU, Pleasic SM, Shapiro JA, et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J Immunol 1994: 152: 3183-3187.
12. Bonifacio E, Genovese S, Braghi S, et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 1995; 38: 816-822.
13. Bingley PJ, Christie MR, Bonifacio E, et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304-1310.
14. Verge CF, Gianani R, Kawasaki E, et al. Prediction of Type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926-933.
15. Vardi P, Crisa L, Jackson RA, et al. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of Type 1 (insulin-dependent) diabetic patients. Diabetologia 1991; 34: 93-102.
16. Pilcher C, Elliott RB. A sensitive and reproducible method for the assay of human islet cell antibodies. J Immunol Methods 1990; 129: 111-117.
17. Vardi P, Dib SA, Tuttleman M, et al. Competitive insulin autoantibody RIA: prospective evaluation of subjects at high risk for development of Type 1 diabetes mellitus. Diabetes 1987; 36: 1286-1291.
18. Bingley PJ, Colman P, Eisenbarth GS, et al. Standardization of IVGTT to predict IDDM. Diabetes Care 1992; 15: 1313-1316.
19. GraphPad Prism [computer program]. Version 2.0. San Diego, CA: GraphPad Software, Inc, 1995.
20. Elliott RB, Pilcher CC. A universal model of antibody prediction (MAP) of type 1 diabetes in children. J Autoimmun 1994; 7: 881-888.